AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Metfra GP1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Lystra Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metfra GP1 Tablet PR

Diabetic patients using Metfra GP1 Tablet PR, a dual-action antidiabetic medication, manage type 2 diabetes mellitus effectively. This combination therapy regulates blood glucose. Consistent daily dosing, always with food, maximizes therapeutic impact. Dosage adjustments are determined by your physician based on blood sugar monitoring. Continuous use is crucial; abrupt cessation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan, encompassing a healthy diet, exercise, and weight control as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Commonly, Metfra GP1 Tablet PR can cause hypoglycemia (low blood sugar). Learn to identify hypoglycemia symptoms: sweating, dizziness, headache, trembling. Always carry a fast-acting glucose source (e.g., sugary snacks or juice) and maintain regular mealtimes. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional side effects may include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor about any history of heart disease before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to check blood cell counts and liver function.

Primary Ingredients of Metfra GP1 Tablet PR

No text provided to rephrase.

Uses of Metfra GP1 Tablet PR

Managing type 2 diabetes

Major Benefits of Metfra GP1 Tablet PR:

Follow your physician's instructions or consult the product label for dosage guidelines. Administer Metfra GP1 Tablet PR with meals.

Common Side effects of Metfra GP1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metfra GP1 Tablet PR:

Follow your doctor's instructions or the package leaflet for dosage. Consume Metfra GP1 Tablet PR with a meal.

How Metfra GP1 Tablet PR works:

Metfra GP1 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metfra GP1 Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metfra GP1 Tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Metformin (GP1) tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metfra GP1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is advised, and regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metfra GP1 Tablet PR cautiously, potentially requiring dose modification. Consult a physician before use. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; it's unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Metfra GP1 Tablet PR :

Should you forget a Metfra GP1 Tablet PR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Metfra GP1 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metfra GP1 Tablet PR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metfra GP1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare but dangerous side effect is particularly risky for patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metfra GP1 Tablet PR and seek immediate medical attention.
Metfra GP1 tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 DM.
Metfra GP1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Metfra GP1 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Metfra GP1 Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Metfra GP1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Metfra GP1 Tablet PR
59
MRP 72
18% off